Does Chronic Low-grade Systemic Inflammation Change Tumor Markers Levels in Patients on Hemodialysis?
Introduction: End-stage renal disease (ESRD) patients are known to have a high risk of developing cancer-related inflammation. Elevated serum levels of tumor markers in ESRD/hemodialysis patients makes analysis and interpretation difficult. Aim: To verify the possible relationship betwe...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2020-12-01
|
Series: | Folia Medica |
Subjects: | |
Online Access: | https://foliamedica.bg/article/51457/download/pdf/ |